Medicinal potential of Panax ginseng and its ginsenosides in atopic dermatitis treatment.
J Ginseng Res
; 44(1): 8-13, 2020 Jan.
Article
em En
| MEDLINE
| ID: mdl-32095092
AD, atopic dermatitis; ATX, plasma autotaxin; Alternative medicine; Atopic dermatitis; CCL2, Chemokine ligand 2; CG, cultivated ginseng; COX-2, Cyclooxygenase-2; DFE, Dermatophagoides farinae body extract; DNFB, 1-fluoro-2,4-dinitrobenzene; EASY, eczema area and severity index; FLG, filaggrin; Filaggrin; GDP, 20-O-ß-d-glucopyranosyl-20(S)-protopanaxadiol; GMCSF, granulocyte macrophage colony-stimulating factor; Ginsenosides; HMC-1, human mast cell line; IFN, interferon; IL, interleukin; KRG, Korean Red Ginseng; LPS, lipopolysaccharide; MCP-1, monocyte chemoattractant protein-1; MDC, macrophage-derived chemokine; MIP-1alpha, macrophage inflammatory protein-1alpha; MIP-1beta, macrophage inflammatory protein-1beta; NO, Nitric oxide; PMA, phorbol-myristate acetate; Panax ginseng; RANTES, regulated on activation normal T cell expressed and secreted; RGE, red ginseng extract; TARC, thymus and activation-regulated chemokine; TEWL, trans epidermal water loss; TH cell, lymphocyte T helper cell; TNCB, 2,4,6-trinitro-1-chlorobenzene; TNF-α, tumor necrosis factor-alpha; TSLP, thymic stromal lymphopoietin
Texto completo:
1
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Terapias_biologicas
/
Plantas_medicinales
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
J Ginseng Res
Ano de publicação:
2020
Tipo de documento:
Article